You already have an account? Log In

What the Yale Universal Health Coverage Study Tells Us About System Design

Posted on 18.08.2026

Every few years, a major piece of health economics research lands with enough force to reset the conversation about how countries pay for medicine. A new projection from the Yale School of Public Health is one of those studies. It estimates that a universal, single-payer health system in the United States would save roughly $1 trillion a year in costs and prevent about 114,000 deaths annually.

For Australian readers, the headline numbers can feel a little abstract — we already have Medicare, and while it has its flaws, no serious politician is proposing to abolish it. But the Yale research isn't really a story about American politics. It's a story about how the design of a health system quietly determines whether people live or die, and how much a nation spends to reach whatever outcome it gets. That has lessons for every country, including ours.

What the study actually claims

The Yale analysis, covered by both the Yale School of Public Health and outlets including Truthout, models what would happen if the United States shifted from its current patchwork of private insurance, employer-based coverage, Medicare and Medicaid to a single-payer system covering everyone. The two headline findings are worth restating carefully:

Cost: An estimated $1 trillion in annual savings, largely from lower administrative overhead, better bargaining power on drugs and services, and reduced downstream costs of untreated illness.
Lives: Roughly 114,000 deaths avoided each year — a figure that reflects people who currently die because they delay care, ration medication, or can't access preventive treatment.

Those aren't fringe claims. They align with a long line of comparative research showing that countries with universal coverage tend to spend less per capita and live longer than the United States. The Yale study is notable because it puts a concrete, contemporary price tag on the gap.

Why the savings are structural, not ideological

The instinct in a lot of political coverage is to treat "single-payer" as a left-wing preference rather than an engineering choice. But the mechanism behind the projected savings is boringly technical.

Roughly speaking, three design features drive the numbers:

1. Administrative simplification

A fragmented insurance market forces hospitals and clinics to employ armies of billing staff to negotiate with dozens of insurers, each with different rules, forms and denial procedures. A single set of rules means fewer administrators, less paperwork, and lower overhead as a share of every dollar spent.

2. Monopsony bargaining

When one payer covers everyone, it can negotiate prices for drugs, devices and procedures on behalf of the whole population. This is why a common medication can cost several times more in the United States than in Australia, the UK or Canada. Our Pharmaceutical Benefits Scheme is essentially a monopsony buyer, and it's a big reason our drug bill is comparatively modest.

3. Preventive access

People who can see a GP without worrying about a bill are more likely to catch problems early. That reduces the number of expensive emergency admissions, amputations, strokes and cardiac events that could have been avoided with a $40 script or a routine screening. The 114,000 lives figure is largely a preventive-care story.

None of that is unique to any particular ideology. Australia, the UK, France, Germany, Japan and Taiwan all achieve universal coverage through very different structures — some single-payer, some multi-payer with heavy regulation — and all spend less per person than the US while achieving better average outcomes.

The politics remain stubborn

If the economics are that clear, why isn't reform easier? The recent US debate is instructive. Senator Bernie Sanders has reintroduced his Medicare for All legislation, arguing that "health care is a human right" and pointing to the Yale numbers as evidence that universal coverage is both cheaper and more humane than the status quo.

Yet within days of the study's release, House Minority Leader Hakeem Jeffries confirmed he does not support Medicare for All, even after being pressed on the 114,000-lives figure. That gap — between what the research supports and what the leadership of a major party is willing to endorse — is the real story of American health policy.

The reasons are familiar. Employer-based insurance covers around 150 million Americans, and the transition costs of unwinding it are politically frightening. The private insurance industry is one of the largest lobbying forces in Washington. And any tax increase required to fund a public system tends to be more visible than the premiums, deductibles and out-of-pocket costs it would replace, even when the net cost to households falls.

What this means for Australia

Australians sometimes underestimate how unusual — and how valuable — our system is. Medicare, the PBS and the mix of public and private hospitals mean that no Australian is one illness away from bankruptcy in the way tens of millions of Americans are. The Yale study is, in effect, a quantification of what we already have.

But it also offers a warning. The savings and lives-saved figures in the study aren't achieved simply by declaring coverage universal. They depend on maintaining the specific design features that make universal systems efficient: strong price negotiation, low administrative fragmentation, and easy access to primary care.

Several trends in Australia chip away at those foundations:

Bulk-billing decline: As fewer GPs bulk-bill, out-of-pocket costs rise, and the preventive-care advantage that drives the mortality savings starts to erode.
Private-public drift: A growing role for private insurance in areas Medicare traditionally covered can reintroduce the administrative complexity that inflates costs in the US.
Workforce shortages: Regional and rural access gaps mean the theoretical universality of Medicare doesn't always translate into practical access.

The Yale study, read from an Australian vantage point, is less a call to adopt something new than a reminder of what's at stake if the fundamentals slip.

Reading health research honestly

Any single study — including this one — comes with caveats. Modelling exercises depend on assumptions about behaviour, prices and implementation. Real transitions are messier than spreadsheets. The $1 trillion figure is a projection, not a guarantee, and different modelling choices could produce meaningfully different numbers.

But the direction of the evidence is remarkably consistent across decades of comparative research: universal systems, well-designed, deliver better health for less money than fragmented private systems. The Yale study is another data point in a very long line pointing the same way.

The interesting question, then, isn't whether universal coverage "works" — dozens of countries have already answered that. It's whether political systems can absorb evidence that runs against entrenched interests. Sanders framing health care as a human right and Jeffries declining to endorse the mechanism most likely to deliver it is a snapshot of that tension. It's a tension worth watching, because the same forces — insurance lobbies, administrative complexity, incremental privatisation — operate in muted form here too.

The bottom line

A trillion dollars and 114,000 lives is not a slogan; it's the estimated annual price of a design choice. Countries that have made the other choice, including Australia, benefit from it every day, often without noticing. The Yale research is a useful prompt to notice — and to defend the parts of our own system that produce those benefits, before we discover their value the hard way.